APPLICATION
ANDA075111
TYPE
ANDA
ORIGINAL APPROVAL
1999-04-22
LATEST ACTION
2002-05-21
ROUTE
INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
IPRATROPIUM BROMIDEDiscontinued
IPRATROPIUM BROMIDE 0.02% · SOLUTION · INHALATION
Approval history
2002-05-21Manufacturing (CMC) · Supplement 9AP
2002-01-25Manufacturing (CMC) · Supplement 8AP
2001-04-03Manufacturing (CMC) · Supplement 7AP
2000-10-23Manufacturing (CMC) · Supplement 3AP
2000-10-23Manufacturing (CMC) · Supplement 1AP
2000-10-23Manufacturing (CMC) · Supplement 2AP
2000-08-17Manufacturing (CMC) · Supplement 5AP
2000-08-17Labeling · Supplement 6AP
2000-08-17Manufacturing (CMC) · Supplement 4AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.